Icahn School of Medicine at Mount Sinai; Columbia University College of Physicians and Surgeons, New York, NY; and The Ohio State University, Columbus, OH.
J Oncol Pract. 2018 Jan;14(1):e23-e33. doi: 10.1200/JOP.2017.025957. Epub 2017 Dec 1.
Black men are more likely to die as a result of prostate cancer than white men, despite effective treatments that improve survival for clinically significant prostate cancer. We undertook this study to identify gaps in prostate cancer care quality, racial disparities in care, and underlying reasons for poorer quality care.
We identified all black men and random age-matched white men with Gleason scores ≥ 7 diagnosed between 2006 and 2013 at two urban hospitals to determine rates of treatment underuse. Underuse was defined as not receiving primary surgery, cryotherapy, or radiotherapy. We then interviewed treating physicians about the reasons for underuse.
Of 359 black and 282 white men, only 25 (4%) experienced treatment underuse, and 23 (92%) of these were black. Most (78%) cases of underuse were due to system failures, where treatment was recommended but not received; 38% of these men continued receiving care at the hospitals. All men with treatment underuse due to system failures were black.
Treatment rates of prostate cancer are high. Yet, racial disparities in rates and causes of underuse remain. Only black men experienced system failures, a type of underuse amenable to health information technology-based solutions. Institutions are missing opportunities to use their health information technology capabilities to reduce disparities in cancer care.
尽管有效的治疗方法可以提高临床显著前列腺癌的生存率,但黑人男性死于前列腺癌的可能性仍然高于白人男性。我们进行这项研究是为了确定前列腺癌护理质量差距、护理中的种族差异以及护理质量较差的根本原因。
我们在两家城市医院确定了所有在 2006 年至 2013 年间诊断为 Gleason 评分≥7 的黑人男性和随机年龄匹配的白人男性,以确定治疗不足的发生率。治疗不足被定义为未接受主要手术、冷冻疗法或放射疗法。然后,我们采访了主治医生,了解治疗不足的原因。
在 359 名黑人男性和 282 名白人男性中,只有 25 名(4%)经历了治疗不足,其中 23 名(92%)为黑人。大多数(78%)治疗不足的病例是由于系统故障导致的,即建议但未接受治疗;其中 38%的患者继续在医院接受治疗。所有因系统故障而治疗不足的男性均为黑人。
前列腺癌的治疗率很高。然而,治疗不足的发生率和原因仍然存在种族差异。只有黑人男性经历了系统故障,这是一种可以通过基于健康信息技术的解决方案来解决的治疗不足类型。医疗机构错过了利用其健康信息技术能力来减少癌症护理中的差异的机会。